Top Markets
Coin of the day
Neuropathix, Inc. Neuropathix, Inc.

Neuropathix, Inc.

NPTX
Rank in Stocks #41304
Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying,... Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying, advancing, and bringing to market innovative treatments derived from its exclusive platform of synthetic cannabinoid derivatives. The company's efforts are concentrated on the research and preclinical development of chemical compounds like KLS-13019, KLS-13023, and KLS-13022, alongside associated molecules and synthetic cannabidiol-based therapies. These investigational drugs are being explored for their potential application in treating various conditions, including chemotherapy-induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy. Previously operating as Kannalife, Inc., the organization rebranded as Neuropathix, Inc. in November 2020. Established in 2010, Neuropathix, Inc. maintains its headquarters in Doylestown, Pennsylvania.
Share Price
$0.0003
Last synced: 2023-06-13
Market Cap
$28.14K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Neuropathix, Inc. (NPTX)

Category

Stock price history for Neuropathix, Inc. (NPTX)
Highest end of day price: $0.00 on 2023-06-01

Lowest end of day price: $3.83 on 2019-12-01
Stock price history of Neuropathix, Inc. from 2019 to 2026
Annual Stock Price Performance
Year Performance
2023 -94.99%
2022 -87.62%
2021 -79.16%
2020 -93.93%
2019 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$527.87 33.33%
US
$873.57 35.10%
NL
$745.48 9.02%
CH
$1.08K -6.68%
KR
$260.24 16.81%
BE